Avant Brands (AVNT) AI Stock Analysis

• Market Cap: C$3.38M
• Dividend Yield: N/A
• Average Volume (3M): 12.51K
• Price to Earnings (P/E): ―
• Beta (1Y): -0.07
• Revenue Growth: 26.36%
• EPS Growth: -8.21%
• Country: CA
• Employees: 180
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): -0.26
• Shares Outstanding: 13,843,431
• 10 Day Avg. Volume: 12,972
• 30 Day Avg. Volume: 12,505
• PEG Ratio: 0.01
• Price to Book (P/B): 0.36
• Price to Sales (P/S): 0.25
• P/FCF Ratio: 1.56
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 42 Neutral
• Price Target: C$0.71 ▼(-29.70% Downside)
• Action: Reiterated Date: 03/12/26
• Date: Action: Reiterated 03/12/26

The score is held down primarily by weak profitability (negative gross profit and ongoing operating/net losses) despite improved recent cash flow. Technicals add further pressure with a downtrend and negative MACD, while valuation is constrained by a negative P/E and no dividend data.

Positive Factors

Improved cash generation

The move to sustained positive operating cash flow and materially higher free cash flow in 2025 indicates the business can generate internal liquidity to fund operations and capex. Over 2–6 months this improves financial flexibility, reduces dependence on external financing, and supports measured reinvestment if sustained.

Scaled revenue base (2020–2024)

Material revenue scaling through 2024 suggests the company achieved distribution, brand traction and market access in regulated channels. A larger revenue base provides a platform to regain margins and realize operating leverage once cost structure and gross profit are restored, improving medium-term outlook.

Moderate leverage

Debt levels around mid-single digit debt-to-equity provide room to navigate volatility without excessive interest burdens. Moderate leverage preserves borrowing capacity and lowers near-term solvency risk, allowing management to prioritize operational fixes and capital allocation over urgent deleveraging.

Negative Factors

Negative gross profit

Negative gross profit is a structural red flag: cost of goods or pricing is misaligned with revenue, so each incremental sale destroys value. Without durable improvements to cultivation, processing costs or premium pricing, margin recovery is required to reach sustainable profitability and long-term viability.

Persistent operating and net losses

Ongoing operating and net losses constrain reinvestment, R&D and marketing, and erode shareholder capital over time. Continued losses necessitate external funding or asset sales, increasing dilution or leverage risk and limiting the company's ability to execute long-term strategic initiatives sustainably.

Balance sheet erosion

Declining assets and equity indicate capital erosion from ongoing losses, reducing the buffer to absorb shocks and limiting strategic flexibility. A weakened balance sheet raises refinancing and credit risks and may constrain the firm's ability to invest in capacity or marketing even if cash flow temporarily improves.

Avant Brands Business Overview & Revenue Model

Company Description

Avant Brands Inc. is a Canadian cannabis company focused on premium cannabis products and brands. The company operates primarily in the cultivation, production, and sale of cannabis and cannabis-derived products, catering to both recreational and medical markets. Avant Brands emphasizes innovation and quality, positioning itself within the competitive landscape of the cannabis industry with a diverse range of offerings, including dried flower, pre-rolls, and infused products.

How the Company Makes Money

Avant Brands makes money primarily by selling cannabis products through regulated channels in Canada. Revenue is generated from the commercialization of its branded cannabis portfolio, which is sold into provincial/territorial wholesale distribution systems for the adult-use market and through medical cannabis channels where applicable. Its earnings are driven by the volumes it can produce and sell, the realized net selling price (influenced by product mix and brand positioning in the premium segment), and its ability to manage cultivation and manufacturing costs. Specific material partnerships, licensing arrangements, or non-cannabis revenue streams: null.

Avant Brands Financial Statement Overview

Summary

Overall financials are mixed: cash flow improved with positive operating and free cash flow in 2023–2025 (including a large jump in 2025), but profitability is weak with negative gross profit in 2024–2025 and persistent operating and net losses. The balance sheet shows moderate leverage but signs of erosion in assets and equity amid ongoing losses.

Income Statement

The company has scaled revenue materially from 2020 to 2024, but growth stalled in 2025 (annual revenue down ~4%). Profitability has deteriorated sharply: gross profit turned negative in 2024–2025, and operating losses remain deep (EBIT and EBITDA negative in every year shown except EBITDA briefly positive in 2023). Net losses persist across the full period, indicating the business has not yet reached a stable, profitable operating model.

Balance Sheet

Leverage is moderate, with debt-to-equity around ~0.38–0.52 in 2023–2024, which is not extreme for the industry. However, the balance sheet has weakened over time as equity and total assets have trended down from 2022–2024, consistent with ongoing losses. Returns on equity are negative across the period, highlighting that shareholder capital is not currently generating profits.

Cash Flow

Cash generation improved meaningfully versus earlier years: operating cash flow shifted from negative (2020–2022) to positive in 2023–2025, and free cash flow is positive in 2023–2025 with a very large jump in 2025 versus 2024. That said, cash flow has been volatile (weak 2024 followed by a surge in 2025), and sustained positive cash generation will need to be proven alongside a return to positive gross profit.

Breakdown	Nov 2025	Feb 2025	Feb 2024	Feb 2023	Nov 2021
Income Statement
Total Revenue	35.90M	35.80M	26.34M	20.15M	9.50M
Gross Profit	-8.01M	-1.68M	12.43M	3.91M	1.90M
EBITDA	-13.82M	-19.45M	4.53M	-1.89M	-9.65M
Net Income	-9.88M	-22.55M	-5.07M	-7.54M	-11.23M
Balance Sheet
Total Assets	49.24M	59.47M	82.55M	67.03M	50.57M
Cash, Cash Equivalents and Short-Term Investments	1.49M	1.74M	794.00K	6.78M	14.49M
Total Debt	15.31M	17.01M	18.70M	3.01M	623.00K
Total Liabilities	24.44M	26.62M	33.22M	18.79M	2.70M
Stockholders Equity	24.80M	32.85M	49.33M	43.92M	47.87M
Cash Flow
Free Cash Flow	5.71M	401.00K	1.85M	-4.90M	-6.22M
Operating Cash Flow	5.75M	507.00K	5.41M	-3.46M	-5.62M
Investing Cash Flow	211.00K	-78.00K	-7.03M	-3.10M	-1.65M
Financing Cash Flow	-6.21M	539.00K	-4.38M	-993.00K	20.96M

Avant Brands Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 1.01
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:AVNT, the sentiment is Negative. The current price of 1.01 is above the 20-day moving average (MA) of 0.76, above the 50-day MA of 0.83, and above the 200-day MA of 0.79, indicating a bearish trend. The MACD of -0.05 indicates Positive momentum. The RSI at 35.80 is Neutral, neither overbought nor oversold. The STOCH value of 31.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:AVNT.

Avant Brands Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
OILS	61 Neutral	C$9.29M	8.94	11.57%	―	-1.14%	―
CLC	57 Neutral	C$7.44M	7.30	-4.55%	―	16.22%	-285.37%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
TGIF	44 Neutral	C$4.96M	13.38	―	―	-2.30%	―
SE	43 Neutral	C$6.59M	-3.18	―	―	-100.00%	-192.62%
AVNT	42 Neutral	C$3.38M	-0.90	-53.71%	―	26.36%	-8.21%

Avant Brands Corporate Events

Avant Brands Retires $1.77 Million in Debt via Premium Unit Issuance

Avant Brands has struck a debt settlement deal with an institutional investor to retire about $1.77 million of its unsecured convertible debenture by issuing 1.9 million units at a deemed price of $0.935, a premium to its current share price. The move will leave Avant with roughly $900,000 outstanding on the debenture and about $728,000 on its secured credit facility, sharply reducing historical debt levels while limiting the creditor’s stake below a control threshold and improving the balance sheet, cash flows and capital structure at a key growth stage for the company.

The most recent analyst rating on (TSE:AVNT) stock is a Hold with a C$0.76 price target. To see the full list of analyst forecasts on Avant Brands stock, see the TSE:AVNT Stock Forecast page.

Avant Brands Posts Turnaround Year with Rising Cannabis Sales and Strong Cash Flow

Avant Brands reported fiscal 2025 results that show a sharp operational turnaround, with gross revenue reaching a record $41.3 million and recreational sales climbing 19% to $14.8 million on the strength of its blk mkt and Tenzo brands. The company swung from a gross loss to a $4.6 million gross profit, cut its net loss by more than half to $9.9 million, generated $5.7 million in operating cash flow, posted positive adjusted EBITDA, and paid down about $4.5 million of debt, underscoring tighter cost control, stronger cash generation and a more resilient balance sheet amid industry headwinds.

The most recent analyst rating on (TSE:AVNT) stock is a Hold with a C$1.00 price target. To see the full list of analyst forecasts on Avant Brands stock, see the TSE:AVNT Stock Forecast page.

Avant Brands Sets Date for Fiscal 2025 Results Release

Avant Brands Inc., a leading Canadian producer of premium indoor-grown cannabis, operates multiple facilities nationwide and serves recreational, medical, and export channels. Its portfolio includes well-known brands such as blk mkt, Tenzo, Cognōscente, flowr, Treehugger, and GreenTec, with distribution across Canada and in international markets including Australia, Israel, and Germany.

The company announced it will release its fourth-quarter and full-year 2025 financial results before markets open on March 2, 2026. The disclosure will provide investors and other stakeholders with an updated view of Avant’s operating performance and may clarify its positioning within the competitive cannabis sector as it continues to expand its domestic and international footprint.

The most recent analyst rating on (TSE:AVNT) stock is a Hold with a C$1.00 price target. To see the full list of analyst forecasts on Avant Brands stock, see the TSE:AVNT Stock Forecast page.

Avant Brands Adopts Shareholder Rights Plan to Guard Against Unsolicited Takeovers

Avant Brands Inc. has adopted a shareholder rights plan designed to give its board and investors more time and flexibility to evaluate and respond to any unsolicited takeover bids. The plan, which aligns with contemporary Canadian corporate governance practices and is not tied to any specific takeover attempt, aims to encourage fair treatment of shareholders and maximize value in the event of a potential bid. It has received conditional approval from the Toronto Stock Exchange and will require ratification by shareholders at the company’s annual general meeting in May 2026, after which it would remain in force for three years, potentially strengthening Avant’s defensive posture and bargaining power in a consolidating cannabis sector.

The most recent analyst rating on (TSE:AVNT) stock is a Hold with a C$1.00 price target. To see the full list of analyst forecasts on Avant Brands stock, see the TSE:AVNT Stock Forecast page.